CARI Health Raises $2.3M in Seed Round to Advance Remote Medication Monitoring
Retrieved on:
Tuesday, January 10, 2023
Health, Medical Devices, Biometrics, Health Technology, Managed Care, General Health, Biotechnology, Digital, University, University of California, San Diego, Health, Environment, Intellectual property, SDAC, Conference, Food, Patient, CARI, SBIR, Food and Drug Administration, Global Entrepreneur, Marianne Schmidl, Fentanyl, Medical device, USD, Medtech, Opioid use disorder, Pharmaceutical industry
Digital health startup CARI Health has closed an oversubscribed $2.3 million seed round that will help it bring the world’s first wearable real-time medication monitor to market.
Key Points:
- Digital health startup CARI Health has closed an oversubscribed $2.3 million seed round that will help it bring the world’s first wearable real-time medication monitor to market.
- The funding will go toward completing first in-patient human clinical studies for CARI Health’s wearable remote medication monitoring device , expanding its intellectual property portfolio, and preparing for the regulatory pathway with the Food and Drug Administration.
- “San Diego Angel Conference Fund IV is excited to lead CARI Health’s successful seed round in 2022,” said Mysty Rusk, founder of the SDAC and Executive Director of USD's Free Enterprise Institute.
- “We are passionate about the potential to make an impact and build something bigger than ourselves,” says CARI Health Founder and CEO Patrik Schmidle .